E
GH icon

Ergoteles’s Guardant Health GH Stock Holding History

Ergoteles’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-111,600
Closed -$4M – 358
2023
Q2 		$4M Buy
+111,600
New +$3.21M 0.19% 130
2022
Q4 		– Sell
-7,600
Closed -$409K – 1616
2022
Q3 		$409K Buy
+7,600
New +$390K 0.01% 837
2022
Q1 		– Sell
-12,050
Closed -$1.21M – 1371
2021
Q4 		$1.21M Buy
+12,050
New +$1.25M 0.05% 367
2021
Q3 		– Sell
-47,135
Closed -$5.85M – 1386
2021
Q2 		$5.85M Buy
47,135
+33,779
+253% +$4.54M 0.13% 202
2021
Q1 		$2.04M Buy
13,356
+7,052
+112% +$1.07M 0.06% 281
2020
Q4 		$812K Sell
6,304
-8,771
-58% -$1.01M 0.03% 365
2020
Q3 		$1.69M Buy
+15,075
New +$1.38M 0.22% 81

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Ergoteles's GH Position: Q3 2023 in Review

Ergoteles sold out of Guardant Health (GH) in Q3 2023, closing a stake of 111,600 shares — an estimated $4M sold.

Ergoteles first reported a position in GH in Q3 2020 and held it in 7 quarters. The position peaked at $5.85M in Q2 2021. 296 funds tracked by Wall St. Rank hold GH as of Q3 2023.

  • Ergoteles reported no remaining Guardant Health position as of Q3 2023 after selling out during the quarter.
  • Ergoteles sold 111,600 Guardant Health shares in Q3 2023, an estimated $4M.
  • Ergoteles first reported a position in Guardant Health in Q3 2020 and held it in 7 quarters.
  • Ergoteles's Guardant Health position peaked at $5.85M in Q2 2021.
  • 296 funds tracked by Wall St. Rank held Guardant Health as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.